Literature DB >> 18781429

The effect of propranolol on cognitive flexibility and memory in acute cocaine withdrawal.

Brendan J Kelley1, Kenneth R Yeager, Tom H Pepper, Robert A Bornstein, David Q Beversdorf.   

Abstract

Upregulated noradrenergic activity occurs early in cocaine withdrawal. Our previous work revealed impaired cognitive flexibility in acute cocaine withdrawal, a cognitive domain that appears to be modulated by noradrenergic activity. Therefore, we wished to determine the effect of beta-adrenergic antagonists on cognitive performance in acute cocaine withdrawal. Eleven subjects acutely withdrawing from cocaine were tested in this pilot study on tasks of cognitive flexibility as well as word fluency, attention, verbal memory, and spatial memory, off and on propranolol in a double-blinded manner. Propranolol significantly benefited certain aspects of cognitive flexibility in acute cocaine withdrawal, and improved some measures of verbal fluency and verbal recall. Cocaine withdrawal treatment is characterized by high failure rates. Further research is needed to determine the role this finding of a reversible cognitive impairment in cocaine withdrawal has in treatment.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18781429     DOI: 10.1080/13554790701846148

Source DB:  PubMed          Journal:  Neurocase        ISSN: 1355-4794            Impact factor:   0.881


  11 in total

Review 1.  Pharmacotherapeutics directed at deficiencies associated with cocaine dependence: focus on dopamine, norepinephrine and glutamate.

Authors:  Colin N Haile; James J Mahoney; Thomas F Newton; Richard De La Garza
Journal:  Pharmacol Ther       Date:  2012-01-31       Impact factor: 12.310

2.  Guanfacine enhances inhibitory control and attentional shifting in early abstinent cocaine-dependent individuals.

Authors:  Helen Fox; Mehmet Sofuoglu; Rajita Sinha
Journal:  J Psychopharmacol       Date:  2015-01-07       Impact factor: 4.153

3.  Over-expectation generated in a complex appetitive goal-tracking task is capable of inducing memory reconsolidation.

Authors:  Amy C Reichelt; Jonathan L C Lee
Journal:  Psychopharmacology (Berl)       Date:  2012-12-13       Impact factor: 4.530

4.  Neuropsychopharmacological regulation of performance on creativity-related tasks.

Authors:  David Q Beversdorf
Journal:  Curr Opin Behav Sci       Date:  2018-09-27

5.  Influence of Serotonin Transporter SLC6A4 Genotype on the Effect of Psychosocial Stress on Cognitive Performance: An Exploratory Pilot Study.

Authors:  David Q Beversdorf; Allen L Carpenter; Jessica K Alexander; Neil T Jenkins; Michael R Tilley; Catherine A White; Ashleigh J Hillier; Ryan M Smith; Howard H Gu
Journal:  Cogn Behav Neurol       Date:  2018-06       Impact factor: 1.600

6.  Functional connectivity during language processing in acute cocaine withdrawal: a pilot study.

Authors:  Ananth Narayanan; Catherine A White; Sanjida S Saklayen; Amir Abduljalil; Petra Schmalbrock; Tom H Pepper; Brad N Lander; David Q Beversdorf
Journal:  Neurocase       Date:  2011-11-14       Impact factor: 0.881

7.  Nondependent stimulant users of cocaine and prescription amphetamines show verbal learning and memory deficits.

Authors:  Martina Reske; Carolyn A Eidt; Dean C Delis; Martin P Paulus
Journal:  Biol Psychiatry       Date:  2010-06-03       Impact factor: 13.382

8.  Single dose propranolol does not affect physiologic or emotional reactivity to smoking cues.

Authors:  Gladys N Pachas; Jodi Gilman; Scott P Orr; Bettina Hoeppner; Sara V Carlini; Elisabeth B Grasser; Tsafrir Loebl; Johanna Nino; Roger K Pitman; A Eden Evins
Journal:  Psychopharmacology (Berl)       Date:  2014-11-22       Impact factor: 4.530

9.  Effect of propranolol on functional connectivity in autism spectrum disorder--a pilot study.

Authors:  Ananth Narayanan; Catherine A White; Sanjida Saklayen; Mary J Scaduto; Allen L Carpenter; Amir Abduljalil; Petra Schmalbrock; David Q Beversdorf
Journal:  Brain Imaging Behav       Date:  2010-06       Impact factor: 3.978

Review 10.  The Role of the Noradrenergic System in Autism Spectrum Disorders, Implications for Treatment.

Authors:  David Q Beversdorf
Journal:  Semin Pediatr Neurol       Date:  2020-06-24       Impact factor: 1.636

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.